Epilepsy is noted in the majority of cases (63.4%) of the human ARHGEF9 mutation syndrome reported to date, and abnormalities in the baseline EEG (31.7%) are also commonly reported (Fig. 1a, b and Supplementary Tables 2, 3). This evidence concerns the gene ARHGEF9 and epilepsy.